Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Nov 03, 2014
Improving the Aerodynamic Performance of Fluticasone Propionate Powders by Tuning Particle Size through Wet Polishing
Read more
Scientific Article
/ Nov 03, 2014
Optimization of a Roller Compaction Process for a Spray Dryer Formulation Using Powder Rheology
Read more
Scientific Article
/ Nov 03, 2014
From Lab to Commercial Spray Drying – Maintaining Powder Properties Across Scales
Read more
Scientific Article